.jpg?w=340&itok=AZLofY9I "EPR in healthcare news."){kind=icon}
Participant-centric study design has advanced, but site-centric execution has not kept pace. In the Journal for Clinical Studies, Brian Mallon examines how unclear expectations, administrative burden and contract delays ...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Embedded and agile – The next phase of the DCT evolution
In this article, Darlene Ellenor Director of Project Operations, Decentralized Clinical Trials Operations highlights how DCTs are now considered a patient centric model for sponsors that want to enhance the patient and site experience and generate more robust data. As DCT evolves, an embedded approach backed by the right processes and tools will maximize the benefits that DCTs bring to clinical research.
-
What’s APAC’s recipe of success in clinical trials market?
Suhail Ali, Vice President, Clinical Operations contributes to this piece in BioSpectrum Asia on the thriving clinical research landscape in the APAC region and the trends driving its growth.
-
.jpg?w=545&itok=Tgn4zMcc "EPR in healthcare news.")
Application of NGS to enhance the molecular monitoring of CML patients
This Q&A with Dr Jin Li and Dr Chad Galderisi of ICON Specialty Laboratory Solutions discusses ICON’s development of its RNA-based next generation sequencing (NGS) assay that detects mutations in chronic myeloid leukemia (CML) and how it can benefit both routine clinics and clinical trial settings.
-
Advancing Research and Development of Multi-indication and Combination Therapies for Obesity
In this article, ICON's Jack Martin explores the impact of comorbidities on obesity therapeutic development including strategic and innovative approaches to therapeutic development and clinical trials design.
-
Enabling evidence-based study endpoint selection
In this article from Applied Clinical Trials, Marcelo Alves Favaro, Associate Outcomes Researcher, MAPI Research Trust, Caprice Sassano, Research Lead - Applied Sciences at HumanFirst and Roya Sherafat, Scientific Director, MAPI Research Trust explore how digital health technologies and patient-centred assessments can be evaluated side-by-side to rapidly select the right tool and the right measures, ultimately reducing patient burden.
-
Overcoming challenges in obesity-related clinical trials
Recent advancements in obesity treatments have spotlighted the field for healthcare providers and developers. In this article from Drug Discovery World, ICON experts share insights on the clinical trials landscape for obesity and why patient centricity is key to overcoming common challenges in the sector.
-
Advancing clinical research through effective data delivery
In this article from The Scientist, Rose Kidd, President of Global Operations Delivery, explains how clinical researchers ensure impeccable data collection and delivery in increasingly complex trials.
-
Winners recognised amid record entries for the PwC Business Post Sustainable Business Awards
This article in the Business Post lists ICON as the winner of the Social and Equality Business of the Year Award category of the 2024 PwC Business Post Sustainable Business Awards.
-
Seeking solutions for more representative populations
This article in Applied Clinical Trials by Tinaya Gray, Global Head of Diversity & Inclusion in Clinical Trials discusses how technology can offer opportunities to leverage tailored solutions that can help drive inclusive diversity in clinical research, to help increase participation from underrepresented patient populations.
-
The State of Obesity-Related Clinical Research: A Q&A session with ICON's Simon Bruce
ICON’s Simon Bruce, Vice President of Internal Medicine and Drug Development Solutions sits down for a Q&A with Pharmaceutical Executive and gives an overview on the obesity survey carried out by ICON in January 2024 and what it suggests about the state of the obesity-related pipeline.
